Predictive value of hematological and inflammatory markers for severity of COVID-19

Introduction and Aim: Coronavirus disease 2019 (COVID–19) can cause damage to a wide variety of organs throughout the body, with the lung being its primary focus of attack. The identification of prognostic indicators in COVID-19 can be of assistance in the management of the disease, in instances tha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicine 2022-07, Vol.42 (3), p.561-566
Hauptverfasser: Ibrahim Abdullah Mahmood, Khalid Ahmed Mahmood, Nahidh Kamel Alwan
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 566
container_issue 3
container_start_page 561
container_title Biomedicine
container_volume 42
creator Ibrahim Abdullah Mahmood
Khalid Ahmed Mahmood
Nahidh Kamel Alwan
description Introduction and Aim: Coronavirus disease 2019 (COVID–19) can cause damage to a wide variety of organs throughout the body, with the lung being its primary focus of attack. The identification of prognostic indicators in COVID-19 can be of assistance in the management of the disease, in instances that are critical or severe. The purpose of this study was to investigate the hematological and inflammatory indicators in COVID-19 patients who were hospitalized and determine how closely those markers are associated with the severity of the condition.   Materials and Methods: In this cross-sectional prospective analysis, there were a total of 200 patients diagnosed with COVID-19. The demographic information and comorbidities of the patients were gathered through direct questioning. The indicators of the complete blood count were recorded for every patient. In addition, tests were performed on D-dimer, ferritin, erythrocyte sedimentation rate (ESR), lactate dehydrogenase (LDH), and C reactive protein (CRP). Systemic immune inflammation index (SII) was calculated. The association of demographic and laboratory parameters with patient’s outcome evaluated.    Results: After a 30-day follow-up, 32 patients (16%) out of 200 required ICU hospitalization, with eight of them (4%) dying. Each of the following od diabetes (OR=4.2; 95 % CI= 1.8-2291, p=0.021), hypertension (OR=3.1, 95 % CI=1.21-19.11, p=0.033), D-dimmer (OR=3.22, 95 % CI=1.43-9.12, p=0.037), ferritin (OR=2.18, 95 % CI=1.4-7.22, p=0.027), NLR (OR=3.26, 95% CI=1.5-7.18, p= 0.023), LDH (OR= 6.23, 95% CI=1.77-22.9, p=0.034), and CRP (OR=4.56, 95% CI=1.32-28.85, p=0.007), were independent risk factors for severity of COVID-19.   Conclusion: The comorbidities diabetes and hypertension, as well as the levels of D-dimer, serum ferritin, NLR, LDH, and CRP, could be utilized to predict COVID-19 severity and its outcome.
doi_str_mv 10.51248/.v42i3.1619
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_51248__v42i3_1619</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_51248__v42i3_1619</sourcerecordid><originalsourceid>FETCH-LOGICAL-c149t-e1fb3638325fb122e4033cf3c7ba3317ab9743b223b5b804c52ef0cd4b4525473</originalsourceid><addsrcrecordid>eNotkMtKxDAYhbNQcBhn5wPkAWxN8idNs5R6GxgYwcs2JGmiwXYqSS307bUzrg4cOB-HD6ErSkpBGa9vyomzCCWtqDpDK6IkKRip5AXa5BwtYZwqwet6hV6ek2-jG-Pk8WS6H4-HgD99b8ahGz6iMx02hxbHQ-hMv7Rpxr1JXz5lHIaEs598iuO8zJr9-_auoOoSnQfTZb_5zzV6e7h_bZ6K3f5x29zuCke5GgtPg4UKamAiWMqY5wTABXDSGgAqjVWSg2UMrLA14U4wH4hrueWCCS5hja5PXJeGnJMP-jvFv3OzpkQfPWh99KAXD_ALhqlSTQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Predictive value of hematological and inflammatory markers for severity of COVID-19</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ibrahim Abdullah Mahmood ; Khalid Ahmed Mahmood ; Nahidh Kamel Alwan</creator><creatorcontrib>Ibrahim Abdullah Mahmood ; Khalid Ahmed Mahmood ; Nahidh Kamel Alwan</creatorcontrib><description>Introduction and Aim: Coronavirus disease 2019 (COVID–19) can cause damage to a wide variety of organs throughout the body, with the lung being its primary focus of attack. The identification of prognostic indicators in COVID-19 can be of assistance in the management of the disease, in instances that are critical or severe. The purpose of this study was to investigate the hematological and inflammatory indicators in COVID-19 patients who were hospitalized and determine how closely those markers are associated with the severity of the condition.   Materials and Methods: In this cross-sectional prospective analysis, there were a total of 200 patients diagnosed with COVID-19. The demographic information and comorbidities of the patients were gathered through direct questioning. The indicators of the complete blood count were recorded for every patient. In addition, tests were performed on D-dimer, ferritin, erythrocyte sedimentation rate (ESR), lactate dehydrogenase (LDH), and C reactive protein (CRP). Systemic immune inflammation index (SII) was calculated. The association of demographic and laboratory parameters with patient’s outcome evaluated.    Results: After a 30-day follow-up, 32 patients (16%) out of 200 required ICU hospitalization, with eight of them (4%) dying. Each of the following od diabetes (OR=4.2; 95 % CI= 1.8-2291, p=0.021), hypertension (OR=3.1, 95 % CI=1.21-19.11, p=0.033), D-dimmer (OR=3.22, 95 % CI=1.43-9.12, p=0.037), ferritin (OR=2.18, 95 % CI=1.4-7.22, p=0.027), NLR (OR=3.26, 95% CI=1.5-7.18, p= 0.023), LDH (OR= 6.23, 95% CI=1.77-22.9, p=0.034), and CRP (OR=4.56, 95% CI=1.32-28.85, p=0.007), were independent risk factors for severity of COVID-19.   Conclusion: The comorbidities diabetes and hypertension, as well as the levels of D-dimer, serum ferritin, NLR, LDH, and CRP, could be utilized to predict COVID-19 severity and its outcome.</description><identifier>ISSN: 0970-2067</identifier><identifier>DOI: 10.51248/.v42i3.1619</identifier><language>eng</language><ispartof>Biomedicine, 2022-07, Vol.42 (3), p.561-566</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c149t-e1fb3638325fb122e4033cf3c7ba3317ab9743b223b5b804c52ef0cd4b4525473</citedby><cites>FETCH-LOGICAL-c149t-e1fb3638325fb122e4033cf3c7ba3317ab9743b223b5b804c52ef0cd4b4525473</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Ibrahim Abdullah Mahmood</creatorcontrib><creatorcontrib>Khalid Ahmed Mahmood</creatorcontrib><creatorcontrib>Nahidh Kamel Alwan</creatorcontrib><title>Predictive value of hematological and inflammatory markers for severity of COVID-19</title><title>Biomedicine</title><description>Introduction and Aim: Coronavirus disease 2019 (COVID–19) can cause damage to a wide variety of organs throughout the body, with the lung being its primary focus of attack. The identification of prognostic indicators in COVID-19 can be of assistance in the management of the disease, in instances that are critical or severe. The purpose of this study was to investigate the hematological and inflammatory indicators in COVID-19 patients who were hospitalized and determine how closely those markers are associated with the severity of the condition.   Materials and Methods: In this cross-sectional prospective analysis, there were a total of 200 patients diagnosed with COVID-19. The demographic information and comorbidities of the patients were gathered through direct questioning. The indicators of the complete blood count were recorded for every patient. In addition, tests were performed on D-dimer, ferritin, erythrocyte sedimentation rate (ESR), lactate dehydrogenase (LDH), and C reactive protein (CRP). Systemic immune inflammation index (SII) was calculated. The association of demographic and laboratory parameters with patient’s outcome evaluated.    Results: After a 30-day follow-up, 32 patients (16%) out of 200 required ICU hospitalization, with eight of them (4%) dying. Each of the following od diabetes (OR=4.2; 95 % CI= 1.8-2291, p=0.021), hypertension (OR=3.1, 95 % CI=1.21-19.11, p=0.033), D-dimmer (OR=3.22, 95 % CI=1.43-9.12, p=0.037), ferritin (OR=2.18, 95 % CI=1.4-7.22, p=0.027), NLR (OR=3.26, 95% CI=1.5-7.18, p= 0.023), LDH (OR= 6.23, 95% CI=1.77-22.9, p=0.034), and CRP (OR=4.56, 95% CI=1.32-28.85, p=0.007), were independent risk factors for severity of COVID-19.   Conclusion: The comorbidities diabetes and hypertension, as well as the levels of D-dimer, serum ferritin, NLR, LDH, and CRP, could be utilized to predict COVID-19 severity and its outcome.</description><issn>0970-2067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNotkMtKxDAYhbNQcBhn5wPkAWxN8idNs5R6GxgYwcs2JGmiwXYqSS307bUzrg4cOB-HD6ErSkpBGa9vyomzCCWtqDpDK6IkKRip5AXa5BwtYZwqwet6hV6ek2-jG-Pk8WS6H4-HgD99b8ahGz6iMx02hxbHQ-hMv7Rpxr1JXz5lHIaEs598iuO8zJr9-_auoOoSnQfTZb_5zzV6e7h_bZ6K3f5x29zuCke5GgtPg4UKamAiWMqY5wTABXDSGgAqjVWSg2UMrLA14U4wH4hrueWCCS5hja5PXJeGnJMP-jvFv3OzpkQfPWh99KAXD_ALhqlSTQ</recordid><startdate>20220703</startdate><enddate>20220703</enddate><creator>Ibrahim Abdullah Mahmood</creator><creator>Khalid Ahmed Mahmood</creator><creator>Nahidh Kamel Alwan</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20220703</creationdate><title>Predictive value of hematological and inflammatory markers for severity of COVID-19</title><author>Ibrahim Abdullah Mahmood ; Khalid Ahmed Mahmood ; Nahidh Kamel Alwan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c149t-e1fb3638325fb122e4033cf3c7ba3317ab9743b223b5b804c52ef0cd4b4525473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Ibrahim Abdullah Mahmood</creatorcontrib><creatorcontrib>Khalid Ahmed Mahmood</creatorcontrib><creatorcontrib>Nahidh Kamel Alwan</creatorcontrib><collection>CrossRef</collection><jtitle>Biomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ibrahim Abdullah Mahmood</au><au>Khalid Ahmed Mahmood</au><au>Nahidh Kamel Alwan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictive value of hematological and inflammatory markers for severity of COVID-19</atitle><jtitle>Biomedicine</jtitle><date>2022-07-03</date><risdate>2022</risdate><volume>42</volume><issue>3</issue><spage>561</spage><epage>566</epage><pages>561-566</pages><issn>0970-2067</issn><abstract>Introduction and Aim: Coronavirus disease 2019 (COVID–19) can cause damage to a wide variety of organs throughout the body, with the lung being its primary focus of attack. The identification of prognostic indicators in COVID-19 can be of assistance in the management of the disease, in instances that are critical or severe. The purpose of this study was to investigate the hematological and inflammatory indicators in COVID-19 patients who were hospitalized and determine how closely those markers are associated with the severity of the condition.   Materials and Methods: In this cross-sectional prospective analysis, there were a total of 200 patients diagnosed with COVID-19. The demographic information and comorbidities of the patients were gathered through direct questioning. The indicators of the complete blood count were recorded for every patient. In addition, tests were performed on D-dimer, ferritin, erythrocyte sedimentation rate (ESR), lactate dehydrogenase (LDH), and C reactive protein (CRP). Systemic immune inflammation index (SII) was calculated. The association of demographic and laboratory parameters with patient’s outcome evaluated.    Results: After a 30-day follow-up, 32 patients (16%) out of 200 required ICU hospitalization, with eight of them (4%) dying. Each of the following od diabetes (OR=4.2; 95 % CI= 1.8-2291, p=0.021), hypertension (OR=3.1, 95 % CI=1.21-19.11, p=0.033), D-dimmer (OR=3.22, 95 % CI=1.43-9.12, p=0.037), ferritin (OR=2.18, 95 % CI=1.4-7.22, p=0.027), NLR (OR=3.26, 95% CI=1.5-7.18, p= 0.023), LDH (OR= 6.23, 95% CI=1.77-22.9, p=0.034), and CRP (OR=4.56, 95% CI=1.32-28.85, p=0.007), were independent risk factors for severity of COVID-19.   Conclusion: The comorbidities diabetes and hypertension, as well as the levels of D-dimer, serum ferritin, NLR, LDH, and CRP, could be utilized to predict COVID-19 severity and its outcome.</abstract><doi>10.51248/.v42i3.1619</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0970-2067
ispartof Biomedicine, 2022-07, Vol.42 (3), p.561-566
issn 0970-2067
language eng
recordid cdi_crossref_primary_10_51248__v42i3_1619
source EZB-FREE-00999 freely available EZB journals
title Predictive value of hematological and inflammatory markers for severity of COVID-19
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T12%3A34%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictive%20value%20of%20hematological%20and%20inflammatory%20markers%20for%20severity%20of%20COVID-19&rft.jtitle=Biomedicine&rft.au=Ibrahim%20Abdullah%20Mahmood&rft.date=2022-07-03&rft.volume=42&rft.issue=3&rft.spage=561&rft.epage=566&rft.pages=561-566&rft.issn=0970-2067&rft_id=info:doi/10.51248/.v42i3.1619&rft_dat=%3Ccrossref%3E10_51248__v42i3_1619%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true